| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/15/2014 | CN103517898A Novel 3-hydroxyisothiazole 1-oxide derivative |
| 01/15/2014 | CN103509071A Preparation and application of active ingredients of glossy privet fruit |
| 01/15/2014 | CN103505603A Traditional Chinese medicine composition for treating agranulocytosis |
| 01/15/2014 | CN103505547A Traditional Chinese medicine composition for treating umbilical hernia |
| 01/15/2014 | CN103505435A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride hard capsule and preparation method thereof |
| 01/15/2014 | CN103505417A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride aerosol and preparation method thereof |
| 01/15/2014 | CN103504288A Heat-clearing and summer-heat-relieving mung bean beverage and preparation method thereof |
| 01/15/2014 | CN102341385B Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/15/2014 | CN102210630B System and method for preparing nosiheptide premix particles |
| 01/15/2014 | CN101880670B 植物血红蛋白 Plants hemoglobin |
| 01/15/2014 | CN101838258B New preparation method of asymmetric synthetic dibenzo dioxy octanone |
| 01/15/2014 | CN101723936B Kinase suppressor and pharmaceutical application thereof |
| 01/14/2014 | US8629134 Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-jk][1]-benzazepin-2[1H]-one and zilpaterol |
| 01/14/2014 | US8628807 Negatively charged polysaccharide derivable from aloe vera |
| 01/14/2014 | US8628775 Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds |
| 01/14/2014 | CA2713673C Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 01/14/2014 | CA2669019C Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 01/14/2014 | CA2561073C Composition and method for cancer treatment |
| 01/14/2014 | CA2418088C Numb protein expression inhibitors by musashi 1 |
| 01/14/2014 | CA2342243C Stable liquid formulations of botulinum toxin |
| 01/09/2014 | WO2014007318A1 Cartilage cell growth promoter |
| 01/09/2014 | WO2014007266A1 Transdermal cancer antigen peptide preparation |
| 01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| 01/09/2014 | WO2014007217A1 Antitumor effect potentiator composed of imidazooxazine compound |
| 01/09/2014 | WO2014005720A1 Use of (r)-phenylpiracetam for the treatment of disease-associated fatigue |
| 01/09/2014 | WO2013106068A3 Therapeutic compositions of specified herbal formulations and uses thereof |
| 01/09/2014 | US20140011815 Fitness assay and associated methods |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/08/2014 | EP2682386A1 Novel vitamin d receptor modulator with partial agonist activity |
| 01/08/2014 | EP2682128A1 Medicinal agent for inhibiting metastasis of malignant tumor |
| 01/08/2014 | EP2682125A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 200 units |
| 01/08/2014 | EP2682124A1 Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units |
| 01/08/2014 | EP2682122A1 Growth hormone secretion promoter |
| 01/08/2014 | EP2681203A1 NOVEL ESTERS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR DISEASE THERAPIES |
| 01/08/2014 | EP2680879A2 Peptide linkers for polypeptide compositions and methods for using same |
| 01/08/2014 | EP2680842A1 Methods of treating a disease or condition of the central nervous system |
| 01/08/2014 | CN103501800A Beautiful-skin-promoting agent and use thereof |
| 01/08/2014 | CN103501795A Antitumor agent containing carbon dioxide as active ingredient |
| 01/08/2014 | CN103501788A Pyridopyrazine derivatives and their use |
| 01/08/2014 | CN103501770A Method for producing patch, and patch |
| 01/08/2014 | CN103497907A Application of bacillus altitudinis in prawn culture |
| 01/08/2014 | CN103497254A Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| 01/08/2014 | CN103495173A Trauma therapy |
| 01/08/2014 | CN103495169A Methods and compositions for treatment and control of multiple myeloma |
| 01/08/2014 | CN103494817A Methods and compoistions used for treatment and control of multiple myeloma |
| 01/08/2014 | CN103494814A Novel applications of Guanfu base A and Guanfu base G |
| 01/08/2014 | CN102716365B TCM preparation for assisting in therapy of shivering and sweating and preparation method |
| 01/08/2014 | CN102698138B Chinese herbal preparation for treating yellowish sweating and preparation method of same |
| 01/08/2014 | CN102264366B Composition containing sesamins and epigallocatechin gallate |
| 01/08/2014 | CN102076660B Sulfonamide compound or salt thereof |
| 01/08/2014 | CN101678088B Modified mutant collagenase and application thereof in fat melting and in scar reduction |
| 01/08/2014 | CN101500559B Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| 01/08/2014 | CN101116666B Compositions of estrogen-cyclodextrin complexes |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623863 Disubstituted azepan orexin receptor antagonists |
| 01/07/2014 | US8623851 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623643 Antisense oligonucleotide modulation of STAT3 expression |
| 01/07/2014 | CA2566625C Thiazole compound and use thereof |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/03/2014 | WO2014004951A1 Novel fatty acid-salicylate conjugates with enhanced therapeutic properties |
| 01/03/2014 | WO2014004902A2 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
| 01/03/2014 | WO2014004470A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
| 01/03/2014 | WO2014003158A1 Indole derivative or salt thereof |
| 01/03/2014 | WO2014003154A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function |
| 01/03/2014 | WO2014003153A1 Substituted amide compound |
| 01/03/2014 | WO2014003124A1 Novel amide derivative and salt thereof |
| 01/03/2014 | WO2014003098A1 Tricyclic compound |
| 01/03/2014 | WO2014002922A1 Method for treating cancer by combined use of anti-cancer agent |
| 01/03/2014 | WO2014002851A1 Solid pharmaceutical tablet and method for producing same |
| 01/03/2014 | WO2014002571A1 Angiotensin-converting-enzyme inhibiting dipeptide |
| 01/03/2014 | WO2013155204A3 Compositions and methods for inhibiting expression of the alas1 gene |
| 01/03/2014 | CA2877953A1 Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function |
| 01/03/2014 | CA2877874A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
| 01/02/2014 | US20140005171 Ophthalmic Ointment Composition Comprising a Drug, an Ointment Base and a Solubilizing/Dispersing Agent |
| 01/02/2014 | US20140005106 Method for administering glp-1 molecules |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004089 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/01/2014 | EP2679586A1 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same |
| 01/01/2014 | EP2679585A1 Glycine transport inhibitor |
| 01/01/2014 | EP2679226A1 Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient |
| 01/01/2014 | EP2133330B1 Atropisomer of pyrrole derivative |
| 01/01/2014 | CN103491954A Use of L-carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function |
| 01/01/2014 | CN103483439A Alpha O-superfamily conotoxin peptide, and medicinal composition and use thereof |
| 01/01/2014 | CN103483234A Cyclopropyl amine derivatives |
| 01/01/2014 | CN103479975A Proved prescription used for treating heatstroke |
| 01/01/2014 | CN103479952A Summer-heat relieving soup |
| 01/01/2014 | CN103479934A Chinese herbal medicine preparation for promoting growth of broiler chicken |
| 01/01/2014 | CN103479846A Proved prescription used for treating heatstroke |
| 01/01/2014 | CN103479768A Composite traditional Chinese medicine compound for treating chronic lymphocytic thyroiditis |
| 01/01/2014 | CN103479725A Proved recipe used for treatment of heatstroke |
| 01/01/2014 | CN103479720A Proved recipe for treating heatstroke |
| 01/01/2014 | CN103479716A Proved prescription used for treating heatstroke |
| 01/01/2014 | CN103479696A Proved prescription used for treating heatstroke |
| 01/01/2014 | CN103479695A Proved recipe used for treatment of heatstroke |
| 01/01/2014 | CN103479596A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride microemulsion soft capsule and preparation method thereof |
| 01/01/2014 | CN103479585A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride tablet and preparation method thereof |
| 01/01/2014 | CN103479581A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride granules and preparation method thereof |